News

Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.
What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with ...
Centene Corp shares fell 25% in after-market trading on Tuesday after the health insurer withdrew its 2025 earnings guidance due to a $1.8 billion shortfall in expected risk adjustment revenue ...
Centene Corp has dropped over 40%, and Adhishthana principles suggest that the decline signals deeper structural issues.
This conjecture is not overly bullish as well, as similarly observed in UNH's ongoing recovery from the May 2025 P/E bottom ...
Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
July 12, 2025) - Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit -- captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) -- seeks to represent ...
Centene (CNC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...
Centene (CNC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Centene is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing ...
Ryan Langston has given his Buy rating due to a combination of factors pertaining to Centene’s stock. Despite the near-term performance challenges expected for the stock, Langston anticipates a ...
We recently compiled a list of the 10 Large-Cap Stocks with Insider Buying in 2025. In this article, we are going to take a look at where Centene Corporation (NYSE:CNC) stands against the other ...